This article is a brief and selected overview of pediatric psychopharmacology, a field which links medicine, behavioural sciences, and neurosciences to child psychiatry. It will summarize current knowledge and recent advances related to the indications, effects, limitations and research issues of psychostimulants, antidepressants, antipsychotics, anxiolytics, anticonvulsants and diets used in the treatment of child and adolescent psychiatric disorders.
References
1.
CampbellM., GreenW.H., DeutschS.I.Child and adolescent psychopharmacology.Beverly Hills, CA: Sage Publications,1985.
2.
ConnersC.K., WerryJ.S.Pharmacotherapy. In: QuayH.C., WerryJ.S., eds. Psychopathological disorders of childhood, second edition.New York: John Wiley and Sons,1979: 336–386.
3.
KleinD.F., GittelmanR., QuitkinF.Diagnosis and drug treatment of psychiatric disorders: adult and children, second edition.Baltimore: Williams and Wilkins, 1980.
4.
RifkinA., WormianR., ReardonG.Psychotropic medication in adolescents: a review.J Clin Psychiatry1986; 47(8): 400–408.
5.
SimeonJ.G.Pediatric psychopharmacology – a review of our findings and experience. In: Siva SankarD.V., ed. Psychopharmacology of childhood.Westbury, New York: PJD Publications Limited,1976: 139–178.
6.
U.S. Department of Health and Human Services.SchoolerN.R., ed. Psychopharmacol Bull, 1985; 21(4).
7.
WerryJ.S.Pediatric psychopharmacology: the use of behavior modifying drugs in children.New York: Brunner/Mazel,1978.
8.
WerryJ.S.The use of psychotropic drugs in children.J Am Acad Child Psychiatry1977; 16(3): 446–447.
9.
WhiteJ.H.Pediatric psychopharmacology: a practical guide to clinical application.Baltimore: Williams and Wilkins Corporation, 1977.
10.
MeltzerH.Y., ed. Psychopharmacology: the third generation of progress.New York: Raven, 1987.
11.
SimeonJ.G., SaletuB.Neurophysiology and child psychiatry. Proceedings of the 11th Congress of the Collegium International Neuro–Psychopharmacologicum, Vienna, 1978. In: SaletuB., BernerP., HollisterL., eds. Neuro–Psychopharmacology.New York: Pergamon Press,1979.
12.
WerryJ.S.Advances in pediatric psychopharmacology, Part I: Introduction.J Am Acad Child Psychiatry1982; 21(1): 1–2.
13.
WerryJ.S.Advances in pediatric psychopharmacology, Part II: Introduction.J Am Acad Child Psychiatry,1982; 21(2): 105–106.
14.
WerryJ.S.An overview of pediatric psychopharmacology.J Am Acad Child Psychiatry1982; 21(1): 3–9.
15.
FergusonH.B., SimeonJ.G.Evaluating drug effects on children's cognitive functioning.Prog Neuropsychopharmacol1984; 8: 683–686.
16.
HechtmanL., WeissG., PerlmanT.Young adult outcome of hyperactive children who received long-term stimulant treatment.J Am Acad Child Psychiatry1984; 23(3): 261–269.
17.
RapoportJ.L., BuchsbaumM., ZahnT.Dextroamphetamine: cognitive and behavioral effects in normal prepubertal boys.Science1978; 199: 560–562.
18.
CantwellD.P., CarlsonG.A.Stimulants. In: WerryJ.S., ed. Pediatric psychopharmacology: the use of behavior modifying drugs in children.New York: Brunner/Mazel1978: 171–207.
19.
FriedJ., GreenhillL., TorresD.Sustained-release methylphenidate: long-term clinical efficacy in ADHD males. Presented at the American Academy of Child and Adolescent Psychiatry, Washington, D.C., October 21–25, 1987.
20.
Gittelman-KleinR.Pharmacotherapy of childhood hyperactivity: an update. In: MeltzerH.Y., ed. Psychopharmacology: the third generation of progress.New York: Raven Press,1987: 1215–1224.
21.
AmanM.G., WerryJ.S.Methylphenidate and diazepam in severe reading retardation.J Am Acad Child Psychiatry1982; 21(1): 31–37.
22.
RudelR.G., HelfgottE.Effect of piracetam on verbal memory of dyslexic boys.J Am Acad Child Psychiatry1984; 23(6): 695–699.
23.
VolavkaJ., SimeonJ., SimeonS.Effects of piracetam on EEG spectra of boys with learning disorders.Psychopharmacology1981; 72: 185–188.
24.
WilsherC.R.A brief review of studies of piracetam in dyslexia.J Psychopharmacol1987; 1(2): 95–100.
25.
CasatC.D., PleasantsD.Z., Van Wyck FleetJ.A double-blind trial of bupropion in children with attention deficit disorder.Psychopharmacol Bull1987; 23(1): 120–122.
26.
CoxW.H.An indication for use of imipramine in attention deficit disorder.Am J Psychiatry1982; 139(8): 1059–1060.
27.
GastfriendD.R., BiedermanJ., JellinekM.S.Desipramine in the treatment of adolescents with attention deficit disorder.Am J Psychiatry1984; 141: 906–908.
28.
SimeonJ.G., FergusonH.B., Van Wyck FleetJ.Bupropion effects in attention deficit and conduct disorders.Can J Psychiatry1986; 31(6): 581–585.
29.
ZametkinA., RapoportJ.L., MurphyD.L.Treatment of hyperactive children with monoamine oxidase inhibitors. II: plasma and urinary monoamine findings after treatment.Arch Gen Psychiatry1985; 42(10): 969–973.
30.
HuntR.D., MinderaaR.B., CohenD.J.Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial.J Am Acad Child Psychiatry1985; 24(5): 617–629.
31.
GualtieriC.T., WarginW., KanoyR.Clinical studies of methylphenidate serum levels in children and adults.J Am Acad Child Psychiatry1982; 21(1): 19–26.
32.
SatterfieldJ.H., CantwellD.P., SchellA.Growth of hyperactive children treated with methylphenidate.Arch Gen Psychiatry1982; 39(4): 486–487.
33.
MattesJ., GittelmanR.Growth of hyperactive children on maintenance methylphenidate.Arch Gen Psychiatry1983; 40: 317–321.
34.
BeckL., LangfordW., MacKayM.Childhood chemotherapy and later drug abuse and growth curve: a follow up study of 30 adolescents.Am J Psychiatry1975; 132: 436–438.
35.
WeissG.The natural history of hyperactivity in childhood and treatment with stimulant medication at different ages: a summary of research findings.Int J Ment Health1975; 4: 213–216.
ZametkinA.J., RapoportJ.L.Noradrenergic hypothesis of attention deficit disorder with hyperactivity: a critical review. In: MeltzerH.Y., ed. Psychopharmacology: the third generation of progress.New York: Raven Press,1987: 837–842.
38.
SokolM.S., CampbellM., GoldsteinM.Attention deficit disorder with hyperactivity and the dopamine hypothesis: case presentations with theoretical background.J Am Acad Child Psychiatry1987; 26: 428–433.
39.
Gittelman-KleinR.Pharmacotherapy of childhood hyperactivity: an update. In: MeltzerH.Y., ed. Psychopharmacology: the third generation of progress, New York: Raven Press, 1987: 1215–1224.
40.
ZametkinA., KaroumF., LinnoilaM.Stimulants urinary catecholamines, and indoleamines in hyperactivity: a comparison of methylphenidate and dextroamphetamine.Arch Gen Psychiatry1985; 42(3): 251–255.
41.
RamentM.F., RapoportJ.L., BergC.B.Clomipramine treatment of childhood obsessive compulsive disorder: a double-blind controlled study.Arch Gen Psychiatry1985; 42(10): 977–983.
42.
Gittelman-KleinR., KleinD.Controlled imipramine treatment of school phobia.Arch Gen Psychiatry1971; 23: 204–207.
43.
RapoportJ.L., MikkelsenE.J.Antidepressants. In: WerryJ.S., ed. Pediatric psychopharmacology: the use of behavior modifying drugs in children.New York: Brunner/Mazel,1978: 208–233.
44.
RapoportJ.L., MikkelsenE.J., ZavadilA.Childhood enuresis. JJ. psychopathology, tricyclic concentration in plasma, and antienuretic effect.Arch Gen Psychiatry1980; 37: 1146–1152.
45.
SimeonJ.G., FergusonH.B.Recent developments in the use of antidepressant and anxiolytic medications.Psychiatr Clin North Amer1985; 8: 893–907.
46.
U.S. Department of Health and Human Services.SchoolerN.R., ed. Psychopharmacol Bull1987; 23(1).
47.
ZametkinA., RapoportJ.L.Tricyclic antidepressants and children. In: BurrowsG., NormanT., DaviesB., eds. Drugs in psychiatry, Volume 1: Antidepressants.Amsterdam: Elsevier Science Publishers,1983: 129–147.
48.
Puig-AntichJ., PerelJ.M., LupatkinW.Imipramine in prepubertal major depressive disorders.Arch Gen Psychiatry1987; 44: 81–89.
49.
GellerB., PerelJ.M., KnitterE.F.Nortriptyline in major depressive disorder in children: response, steady state plasma levels, predictive kinetics and pharmacokinetics.Psychopharmacol Bull1983; 19: 62–65.
50.
LakeC.R., MikkelsenE.J., RapoportJ.L.Effect of imipramine on norepinephrine and blood pressure in enuretic boys.Clin Pharmacol Ther1979; 26: 647–653.
51.
PreskornS., WellerE., WellerR.A.Plasma levels of imipramine and adverse effects in children.Am J Psychiatry1983; 140: 1332–1335.
52.
PreskornS., WellerE., WellerR.A.Depression in children: relationship between plasma imipramine levels and response.J Clin Psychiatry1982; 43(11): 450–453.
53.
ShafferD., HedgeB., StephensonJ.Trial of an alpha-adrenolytic drug (indoramin) for nocturnal enuresis.Dev Med Child Neurol1978; 20: 183–188.
54.
StephensonJ.D.Physiological and pharmacological basis for the chemotherapy of enuresis.Psychol Med1979; 9: 249–-263.
55.
GarfinkelB.D., WenderP.H., SlomanL.Tricyclic antidepressant and methylphenidate treatment of attention deficit disorder in children.J Am Acad Child Psychiatry1983; 22(4): 343–348.
56.
SimeonJ.G., MaguireJ., LawrenceS.Maprotiline effects in children with enuresis and behavioral disorders.Prog Neuropsychopharmacol1981; 5: 495–498.
57.
LangerD.H., RapoportJ.L., EbertM.Pilot trial of mianserin hydrochloride for childhood hyperactivity. In: ShopsinB., GreenhillL., eds. The psychobiology of childhood: a profile of current issues.New York: Spectrum Publications,1984: 197–210.
58.
ZametkinA., RapoportJ.L., MurphyD.L.Treatment of childhood attention deficit disorder with hyperactivity with monamine oxidase inhibitors. I: Clinical efficacy.Arch Gen Psychiatry1985; 42(10): 962–966.
59.
BerneyT., KolvinI., BhateS.R.School phobia: a therapeutic trial with clomipramine and short-term outcome.Br J Psychiatry1981; 138: 110–118.
60.
GarfinkelB.D., BernsteinG.A.Paper presented at the Annual Meeting of American and Canadian Academies of Child Psychiatry, Toronto, 1984.
61.
Puig-AntichJ., GoetzR., HanlonC.Sleep architecture and REM sleep measures in prepubertal children with major depression.Arch Gen Psychiatry1982; 39: 932–939.
62.
AmbrosiniP.J.Pharmacotherapy in child and adolescent major depressive disorder. In: MeltzerH.Y., ed. Psychopharmacology: the third generation of progress.New York: Raven Press,1987: 1247–1254.
63.
KramerA.D., FeiguineR.J.Clinical effects of amitriptyline in adolescent depression.J Am Acad Child Psychiatry1981; 20(3): 636–644.
64.
RyanN., Puig-AntichJ., CooperT.Imipramine in adolescent major depression: plasma level and clinical response.Acta Psychiatr Scand1986; 73: 275–288.
65.
RyanN.Li/TCA Augmentation Adolescent MDD.J Am Acad Child Psychiatry1988; 27(3): 371–376.
66.
RyanN.MAOIs in adolescent major depression.J Am Acad Child Psychiatry (in press), 1988.
67.
SimeonJ.G., FergusonH.B.Efficacy and safety of fluoxetine in the treatment of depressive disorders in adolescents. Presented at the Annual Meeting of the American College of Neuropsychopharmacology, Washington, D.C., December 8–12, 1986.
68.
RapoportJ.L.Pediatric psychopharmacology: the last decade. In: MeltzerH.Y., ed. Psychopharmacology: the third generation of progress.New York: Raven Press,1987: 1211–1214.
69.
FlamentM.F., RapoportJ.L., MurphyD.S.Biochemical changes during clomipramine treatment of childhood obsessive-compulsive disorder.Arch Gen Psychiatry1987; 44: 219–225.
70.
CampbellM., SmallA.M., GreenW.H.Behavioral efficacy of haloperidol and lithium carbonate: a comparison in hospitalized aggressive children with conduct disorder.Arch Gen Psychiatry1984; 41(7): 650–656.
71.
PolizosP., EngelhardtD.M., HoffmanS.P.Neurological consequences of psychotropic drug withdrawal in schizophrenic children.J of Autism Child Schizophrenia1973; 3(3): 247–253.
72.
GualtieriC.T., QuadeD., HicksR.E.Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents.Am J Psychiatry1984; 141(1): 20–23.
73.
CampbellM., PerryR., BennettW.G.Long-term therapeutic efficacy and drug-related abnormal movements: a prospective study of haloperidol in autistic children.Psychopharmacol Bull1983; 19(1): 80–83.
74.
KlykyloW.M., FeldisD., O'GradyD.Brief report: clinical effects of fenfluramine in ten autistic subjects.J Autism Dev Disord1985; 15(4): 417–423.
75.
RitvoE.R., FreemanB.J., GellerE.Effects of fenfluramine on 14 outpatients with the syndrome of autism.J Am Acad Child Psychiatry1983; 22(6): 549–558.
76.
CampbellM., SmallA.M., PalijM.The efficacy and safety of fenfluramine in autistic children: preliminary analysis of a double-blind study.Psychopharmacol Bull1987; 23(1): 123–127.
77.
BruunR.D.Gilles de la Tourette's syndrome: an overview of clinical experience.J Am Acad Child Psychiatry1984; 23(2): 126–133.
78.
ShapiroA.K., ShapiroE.Controlled study of pimozide vs. placebo in Tourette's syndrome.J Am Acad Child Psychiatry1984; 23(2): 161–173.
79.
LeckmanJ.F., DetlorJ., HarcherikD.F.Acute and chronic clonidine treatment in Tourette's syndrome: a preliminary report on clinical response and effect on plasma and urinary catecholamine metabolites, growth hormone and blood pressure.J Am Acad Child Psychiatry1983; 22(5): 433–440.
80.
CaineE.D., LudlowC.L., PolinskyR.J.Provocative drug testing in Tourette's syndrome: d- and 1- amphetamine and haloperidol.J Am Acad Child Psychiatry1984; 23(2): 147–152.
81.
GittelmanR.Anxiety disorders of childhood.New York: Guildford Press,1986.
82.
SimeonJ.G., FergusonH.B.Treatment of sleep disturbances in children: recent advances. In: NoshpitzJ., HarrisonS., eds. Basic handbook of child psychiatry.New York: Basic Books Inc.,1987: 470–478.
83.
GlickG.S., SchulmanD., TureckiS.Diazepam treatment in childhood sleep disorders.Dis Nerv Syst1971; 32(8): 565–566.
ReimaoR., LefevreA.Evaluations of flurazepam and placebo on sleep disorders in childhood.Arq Neurospiquiatr1982; 40: 1–13.
86.
PopoviciuL., CorfariuO.Efficacy and safety of midazolam in the treatment of night terrors in children.Br J Clin Pharmacol1983; 16: 97–102.
87.
SimeonJ.G., FergusonH.B.Alprazolam effects in children with anxiety disorders.Can J Psychiatry1987; 32(7): 570–574.
88.
WiezmanA., TyanoS., WijsenbeckH.High-dose diazepam treatment and its effect on prolactin in adolescent schizophrenic patients.Psychopharmacology1984; 82: 382–385.
89.
Ranier-PopeC.R.Treatment with diazepam of children with drug-induced extrapyramidal symptoms.S Af Medi J1979; 55: 328–330.
90.
SimeonJ.G.Biology and therapy of violent behavior in children. In: ObiolsJ., BallusC., MonclusE.G., PujolJ., eds. Biological psychiatry today.Amsterdam: Elsevier/North Holland Biomedical Press,1979: 1223–1228.
91.
CampbellM., CohenI.L., SmallA.M.Drugs in aggressive behavior.J Am Acad Child Psychiatry1982; 21(2): 107–117.
92.
GreenhillL.L., RiederR.O., WenderP.H.Lithium carbonate in the treatment of hyperactive children.Arch Gen Psychiatry1973; 28: 636–640.
93.
AmeryB., MinichielloM.D., BrownG.L.Aggression in hyperactive boys: response to d-amphetamine.J Am Acad Child Psychiatry1984; 23(3): 291–294.
94.
WilliamsD.T., MehlR., YudofskyS.The effect of propranolol on uncontrolled rage outbursts in children and adolescents with organic brain dysfunction.J Am Acad Child Psychiatry1982; 21(2): 129–135.
95.
StoresG.Antiepileptics (anticonvulsants). In: WerryJ.S., ed. Pediatric psychopharmacology: the use of behavior modifying drugs in children.New York: Brunner/Mazel,1978: 274–315.
96.
FeingoldB.F.Why your child is hyperactive.New York: Random House, 1975.
97.
ConnersC.K.Food additives and hyperactive children.New York: Plenum Press, 1980.
